Key result
Severe atrial functional TR is linked to ~2.8-fold higher mortality in severe atrial cardiomyopathy.
Why the study?
The prevalence, determinants, and prognostic significance of atrial functional tricuspid regurgitation in patients with severe atrial cardiomyopathy remained incompletely defined.
Observational (n=214)
No
In patients with severe atrial cardiomyopathy, atrial functional tricuspid regurgitation is highly prevalent (19% severe) and independently predicts a nearly threefold higher risk of long-term all-cause mortality.
Severe atrial functional tricuspid regurgitation was associated with higher mortality in severe atrial cardiomyopathy; extends prognostic assessment but requires prospective validation.
Background The prevalence and prognostic significance of atrial functional tricuspid regurgitation (AF-TR) in patients with severe atrial cardiomyopathy (AtCM) remain incompletely defined. Purpose To evaluate the prevalence, determinants, and prognostic significance of AF-TR in patients with severe AtCM. Methods We conducted a prospective observational study including consecutive patients with severe left atrial dilatation (left atrial volume index ≥50 mL/m²) admitted to a tertiary cardiology department. Patients with left ventricular ejection fraction <50%, primary valvular disease, left ventricular hypertrophy, significant pulmonary hypertension, or implanted cardiac devices were excluded. All patients underwent comprehensive echocardiography, including volumetric and speckle-tracking analysis. Tricuspid regurgitation (TR) was graded according to current guidelines. Multivariable logistic regression was used to identify determinants of severe AF-TR. Cox proportional hazards regression analysis was performed to identify predictors of all-cause mortality. Results A total of 214 patients were included (mean age 73.8±9.6 years; 59% women). Mild AF-TR was present in 51%, moderate in 30%, and severe in 19%. Over a median follow-up of 40 months (IQR 23–57), overall mortality was 25%. Mortality increased according to AF-TR severity (16% in mild, 22% in moderate, and 55% in severe AF-TR; log-rank p<0.0001). Multivariable logistic regression analysis demonstrated that severe AF-TR was independently associated with heart failure (OR 12.8, 95% CI 2.7–21.4; p=0.001), permanent atrial fibrillation (OR 2.9, 95% CI 1.2–6.9; p=0.014), female sex (OR 2.9, 95% CI 1.2–7.2; p=0.020), and chronic kidney disease (OR 2.8, 95% CI 1.1–7.5; p=0.039). In a separate model including echocardiographic parameters, right atrial volume index (OR 1.10 per 1 mL/m² increase, 95% CI 1.05–1.17; p=0.001) and tricuspid annular diameter (OR 1.08 per 1 mm increase, 95% CI 1.02–1.16; p=0.016) were independently associated with severe AF-TR. In Cox regression analysis, heart failure (HR 3.4, 95% CI 1.5–7.6; p=0.003), severe AF-TR (HR 2.8, 95% CI 1.5–5.2; p=0.001), and chronic kidney disease (HR 2.3, 95% CI 1.3–3.8; p=0.003) independently predicted mortality. Conclusion In patients with severe atrial cardiomyopathy, AF-TR is highly prevalent and identifies individuals at increased risk of long-term mortality, underscoring the importance of systematic evaluation and timely management of tricuspid regurgitation.
No takes yet. Share an insight, caveat, or question.
Ilieva et al. (2026) conducted an observational in Severe atrial cardiomyopathy with atrial functional tricuspid regurgitation (n=214). Severe atrial functional tricuspid regurgitation (AF-TR) vs. Mild or moderate AF-TR was evaluated on All-cause mortality (HR 2.8, 95% CI 1.5-5.2, p=0.001). Severe atrial functional tricuspid regurgitation independently predicted all-cause mortality in severe atrial cardiomyopathy (HR 2.8; 95% CI 1.5-5.2; p=0.001), with 55% vs 16% mortality in mild AF-TR.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: